Dr. John Berdahl named Top 40 under 40 worldwide by The Ophthalmologist

SIOUX FALLS, S.D., Dec. 14, 2016 /PRNewswire/ -- Dr. John Berdahl was recently named Top 40 under 40, worldwide, in the field of ophthalmology by Britain's trade journal The Ophthalmologist.  This honor was bestowed upon him for his accomplishments as a physician, educator, and inventor. 

Dr. Berdahl specializes in advanced cataract, corneal and glaucoma surgery, in addition to refractive surgery. He practices at Vance Thompson Vision in Sioux Falls, an internationally recognized refractive surgery practice specializing in advanced eye surgeries.

Dr. Berdahl graduated from Mayo Medical School and finished his ophthalmology residency at Duke University. He also completed an anterior segment fellowship at Minnesota Eye Consultants. He has won numerous national awards including the Claes Dohlman Award from Harvard University, given to the top cornea fellow in America, and the Resident Writers Award from the American Academy of Ophthalmology. In 2013, he was named the top young physician in South Dakota. His commitment to those in need is demonstrated by his leadership role in EyeCare America (which provides free eye care to the underserved) and by the numerous surgical mission trips he continues to participate in worldwide.

"John is an exceptional surgeon, innovator, and thought leader," says Dr. Vance Thompson, one of his partners at Vance Thompson Vision in Sioux Falls. "His patient care is second to none, and his ability to think creatively and provide practical solutions makes his presence on our team invaluable."

Dr. Berdahl is also the CEO and Founder of Equinox, a medical device company that aims to treat glaucoma by leveraging some of his team's discoveries of the role intracranial pressure plays in glaucoma and visual impairment suffered by astronauts on the international space station. Because of this work, he was appointed to the Vision for Mars team, collaborating with NASA and the NSBRI.  Additionally he has developed a sublingual anesthetic to help minimize the need for IVs during cataract surgery. He has also developed a widely used mathematical algorithm to solve the complicated problem of astigmatism following cataract surgery. 

Dr. Berdahl is on the leading edge of innovation in ophthalmology and has presented on innovations in glaucoma, cataract and refractive surgery on four continents. He is also the current president of the Vanguard Ophthalmology Society, which is dedicated to the excellence and advancement of ophthalmology.

"I feel lucky to be recognized for doing work that I love, and helping patients in their moments of vulnerability.  Really, I am getting more credit than I deserve because of the hard work performed by my colleagues," said Dr. Berdahl about the honor. 

About Vance Thompson Vision
Vance Thompson Vision, Sioux Falls, SD and Fargo, ND, is a world-class refractive surgery center and research institute. Vance Thompson Vision provides and participates in developing the world's most exceptional technologies to improve outcomes in surgical care; all while creating a patient experience that is second to none. With more than 100,000 procedures, more than 80 FDA monitored clinical trials, and having traveled the world to advance the learning of providers everywhere, Vance Thompson Vision is the standard in quality and innovation. For more information on the international reputation of the doctors that lead studies such as this one visit the biographies of Dr. Vance Thompson, Dr. Alison Tendler, Dr. John Berdahl, Dr. Michael Greenwood, Dr. Doug Wallin, Dr. Keith Rasmussen, Dr. Justin Schweitzer, Dr. Jason Schmit, and Dr. Mitch Ibach.

Contact:  Matt Jensen   CEO: Sioux Falls, SD   (605) 371-7120 / [email protected]

SOURCE Vance Thompson Vision